Guest guest Posted February 13, 2011 Report Share Posted February 13, 2011 Although many of us would like to participate in CAL-101 or similar trials, the expense (personal and financial) is often prohibitive. For the broader patient base, there are no other options other than those that can be provided locally. We are 4 to 5 years away from drugs currently in the pipeline. Others on this list have written more eloquently about this topic than I. Ann Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.